KeyBanc raised the firm’s price target on HealthEquity (HQY) to $125 from $100 and keeps an Overweight rating on the shares.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HQY:
- Morning Movers: Chart Industries, Flowserve both rise following merger pact
- HealthEquity price target raised to $117 from $112 at RBC Capital
- HealthEquity price target raised to $125 from $110 at BofA
- Healthequity’s Strong Financial Performance and Strategic Initiatives Drive Buy Rating
- HealthEquity price target raised to $117 from $110 at Citizens JMP